# Cambridge Cognition Holdings plc

- Link: https://www.directorstalkinterviews.com/company/cambridge-cognition-holdings-plc/cog.l
- Published: 2020-11-06T13:24:33+00:00
- Author: Giles

**Cambridge Cognition Holdings plc** (LON:COG) is a world leading neuroscience technology
company committed to enhancing global research, accelerating treatment development
and improving patient outcomes in conditions affecting brain health by optimising
the assessment of cognition.

**DRUG** Development

**DIGITAL **Health

**COGNITIVE** Research

![Cambridge Cognition](https://www.directorstalkinterviews.com/wp-content/uploads/
2020/11/Cambridge-Cognition-Drug-Development.jpg "Cambridge Cognition Holdings plc(
COG)")

![Cambridge Cognition](https://www.directorstalkinterviews.com/wp-content/uploads/
2020/11/Cambridge-Cognition-Digital-Health.jpg "Cambridge Cognition Holdings plc(
COG)")

![Cambridge Cognition](https://www.directorstalkinterviews.com/wp-content/uploads/
2020/11/Cambridge-Cognition-Research.jpg "Cambridge Cognition Holdings plc (COG)")

**Maximise The Chances Of Success In Clinical Trials**

Industry-leading and regulatory-accepted digital products to optimise and accelerate
safe, effective and efficient drug development.

 * Enrich clinical trial recruitment
 * Develop new treatments
 * Improve patient outcomes

**Assess And Improve Brain Health And Mental Wellbeing**

Medical devices and digital health technology to collect real world outcomes data,
identify patients, detect impairments early, and track wellbeing over time. 

 * Alzheimer’s screening
 * Cognitive health assessments
 * Mental health at work

**The Gold Standard In Cognitive Assessment**

The world’s most recognised digital cognitive testing platform for all areas of 
brain research providing sensitive assessment of cognitive domains in-person and
online. 

 * CANTAB cognitive assessments
 * Training and support
 * Neurocience consultancy
